Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects With Parkinson's Disease


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04912115

Organisation Name: PharmaTher Inc.

Overal Status: Not yet recruiting

Start Date: July 6, 2021

Last Update: June 3, 2021

Lead Sponsor: PharmaTher Inc.

Brief Summary: A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo-Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa-Induced Dyskinesia in Subjects with Parkinson's Disease.

Conditions:
  • Dyskinesias
  • Movement Disorders
  • Central Nervous System Diseases
  • Nervous System Diseases
  • Neurologic Manifestations


Total execution time in seconds: 0.17215299606323